pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

Hospitals Turn to Longevity Clinics as New Revenue Stream

Oct 16, 2026·read at STAT ↗Neutral

STAT's biotech podcast "The Readout LOUD" featured a discussion about the rapid growth of longevity clinics that are being opened by hospitals.

Reporters noted that the longevity medicine market is projected to be worth multiple trillions, and hospitals see these clinics as a potential new source of revenue.

The conversation explored what services these clinics offer, ranging from anti‑aging treatments to metabolic health programs, and raised questions about the scientific evidence behind them.

The episode highlighted the broader interest of the healthcare system in catering to patients seeking to extend healthspan, signaling a shift toward preventive and longevity‑focused care.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Hospitals’ next lucrative bet — longevity clinics”

read at STAT ↗
528 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
NOVARTISNOVONovo Nordisk Inc
drugs
Obesity2
topics
Obesity2Endocrinology & Metabolism

related stories

  • Sep 17Novo notches up to $1.4B pact with Orbis to develop oral macrocycle cardiometabolic drugsBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Aug 24Roche commits to lean-mass preservation with Hanmi obesity dealBioPharma Dive
  • Aug 24Roche bets up to $2.3B in Hanmi pact for next-gen weight loss drugBioSpace
  • Aug 21Novo Nordisk starts trialing lower maintenance doses of oral WegovyBioSpace